Monday, October 17, 2016

Mucinex D



guaifenesin and pseudoephedrine hydrochloride

Dosage Form: tablet, extended release
Mucinex®D

Drug Facts









Active ingredients (in each extended-release bi-layer tablet)Purpose
Guaifenesin 600 mgExpectorant
Pseudoephedrine HCl 60 mgNasal Decongestant

Uses


  • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

  • temporarily relieves nasal congestion due to:
    • common cold

    • hay fever

    • upper respiratory allergies


  • temporarily restores freer breathing through the nose

  • promotes nasal and/or sinus drainage

  • temporarily relieves sinus congestion and pressure


Warnings



Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.



Ask a doctor before use if you have


  • heart disease

  • high blood pressure

  • thyroid disease

  • diabetes

  • trouble urinating due to an enlarged prostate gland

  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema

  • cough accompanied by too much phlegm (mucus)


When using this product


  • do not use more than directed


Stop use and ask a doctor if


  • you get nervous, dizzy, or sleepless

  • symptoms do not get better within 7 days, come back or occur with a fever, rash, or persistent headache. These could be signs of a serious illness.


If pregnant or breast-feeding, ask a health professional before use.



Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.



Directions


  • do not crush, chew, or break tablet

  • take with a full glass of water

  • this product can be administered without regard for timing of meals

  • adults and children 12 years and older: 2 tablets every 12 hours; not more than 4 tablets in 24 hours

  • children under 12 years of age: do not use


Other information


  • tamper evident: do not use if carton is open or if printed seal on blister is broken or missing

  • store at 20-25°C (68-77°F)


Inactive ingredients


carbomer 934P, NF; FD&C yellow #6 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF



Distributed by:

Reckitt Benckiser Inc.

Parsippany, NJ 07054-0224

©RBI 2009



PRINCIPAL DISPLAY PANEL - 600 mg Carton


NDC 63824-057-18


Mucinex®D


600 mg guaifenesin & 60 mg pseudoephedrine HCl

extended-release bi-layer tablets


EXPECTORANT & NASAL DECONGESTANT


12 HOUR


NEW LOOK-

SAME RELIEF


Thins And Loosens Mucus


Clears Nasal/Sinus Congestion


18 EXTENDED-RELEASE BI-LAYER TABLETS










Mucinex D 
guaifenesin and pseudoephedrine hydrochloride  tablet, extended release










Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)63824-057
Route of AdministrationORALDEA Schedule    











Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Guaifenesin (Guaifenesin)Guaifenesin600 mg
Pseudoephedrine Hydrochloride (Pseudoephedrine)Pseudoephedrine Hydrochloride60 mg





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
ColorORANGE, WHITEScoreno score
ShapeOVALSize16mm
FlavorImprint CodeMucinex;600
Contains      






















Packaging
#NDCPackage DescriptionMultilevel Packaging
163824-057-182 BLISTER PACK In 1 CARTONcontains a BLISTER PACK
19 TABLET In 1 BLISTER PACKThis package is contained within the CARTON  (63824-057-18)
263824-057-364 BLISTER PACK In 1 CARTONcontains a BLISTER PACK
29 TABLET In 1 BLISTER PACKThis package is contained within the CARTON  (63824-057-36)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02158504/17/2009


Labeler - Reckitt Benckiser, Inc. (094405024)
Revised: 12/2009Reckitt Benckiser, Inc.




More Mucinex D resources


  • Mucinex D Side Effects (in more detail)
  • Mucinex D Dosage
  • Mucinex D Use in Pregnancy & Breastfeeding
  • Mucinex D Drug Interactions
  • Mucinex D Support Group
  • 50 Reviews for Mucinex D - Add your own review/rating


  • Mucinex D Consumer Overview

  • Congestac MedFacts Consumer Leaflet (Wolters Kluwer)

  • Entex PSE Controlled-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Pseudovent Consumer Overview

  • Robitussin Severe Congestion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Zephrex LA Sustained-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Mucinex D with other medications


  • Cough and Nasal Congestion

No comments:

Post a Comment